|
OMIM |
Link |
Information gain |
01 |
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000210379
|
|
|
TNF
|
[NCBI]
|
8.65308e-05
|
|
|
MDD
|
[NCBI]
|
6.50969e-05
|
|
|
SLPI
|
[NCBI]
|
4.88055e-05
|
|
|
CVID
|
[NCBI]
|
4.8685e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
4.03246e-05
|
|
|
KIR2DL2
|
[NCBI]
|
3.91613e-05
|
|
|
KIR2DL3
|
[NCBI]
|
3.91613e-05
|
|
|
KRT7
|
[NCBI]
|
3.65682e-05
|
|
|
CCL5
|
[NCBI]
|
3.5311e-05
|
|
|
KIR2DL1
|
[NCBI]
|
3.47699e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.12347e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
3.00383e-05
|
|
|
CXCL12
|
[NCBI]
|
2.8419e-05
|
|
|
HLA-A
|
[NCBI]
|
2.24722e-05
|
|
|
IFNA1
|
[NCBI]
|
2.12022e-05
|
|
|
PI
|
[NCBI]
|
1.56668e-05
|
|
|
XDH
|
[NCBI]
|
1.05971e-05
|
|
|
SLE
|
[NCBI]
|
8.7745e-06
|
|
|
ADA
|
[NCBI]
|
8.76601e-06
|
|
|
VDR
|
[NCBI]
|
7.09253e-06
|
|
|
EPO
|
[NCBI]
|
3.17787e-06
|
|
|
RA
|
[NCBI]
|
1.93037e-06
|
|
|
NPY
|
[NCBI]
|
1.88908e-06
|
|